Use of cyclosporine

Transplantation

Volumn 74, Issue 6, 2002, Pages 754-755

  Asai, T ^a   Nakatani, T ^a   Yamanaka, S ^a   Tamada, S ^a   Kishimoto, T ^a   Tashiro, K ^a   Nakao, T ^a   Okamura, M ^a   Iwao, H ^a   Miura, K ^a   Paul, Leendert C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE MAGNESIUM; CYCLOSPORIN A; MAGNESIUM OXIDE;

DRUG USE; HUMAN; HYPOMAGNESEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; NONHUMAN; NOTE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

EID: 0037183862     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200209270-00002     Document Type: Note

References (5)

1. Pere A-K, Krogerus L, Mervaala EMA, et al. Detrimental effect of dietary sodium and beneficial effect of dietary magnesium on glomerular changes in cyclosporine-A-treated spontaneously hypertensive rats. Nephrol Dial Transplant 1998;13:904.
2. Pere A-K, Krogerus L, Mervaala EMA, et al. Beneficial effects of dietary magnesium and potassium on cardiac and renal morphologic features in cyclosporin A-induced damage in spontaneously hypertensive rats. Surgery 2000;128: 67.
3. Burdmann EA, Andoh TF, Lindsley J, et al. Effects of oral magnesium supplementation on acute experimental cyclosporin nephrotoxicity. Nephrol Dial Transplant 1994;9:16.
4. Miura K, Najatani T, Asai T, et al. Role of hypomagnesemia in chronic cyclosporine nephropathy. Transplantation 2002;73:340.
5. Nguyen T, Steiner RW. A trial of oral magnesium supplementation in renal transplant recipients receiving cyclosporine. Transplant Proc 1998;30:4317.